The tumor-necrosis-factor-associated periodic syndrome, the brain, and tumor-necrosis-factor-alpha antagonists.
Wildemann
B
B
Division of Molecular Neuroimmunology, Department of Neurology, University of Heidelberg, Germany.
Rudofsky
G
G
Kress
B
B
Jarius
S
S
Konig
F
F
Schwenger
V
V
D000328:Adult; D019943:Amino Acid Substitution; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D020274:Autoimmune Diseases of the Nervous System / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000235:genetics; D001921:Brain / Q000276:immunology* / Q000473:pathology; D003937:Diagnosis, Differential; D004673:Encephalomyelitis, Acute Disseminated / Q000175:diagnosis; D000068800:Etanercept; D005076:Exanthema / Q000209:etiology; D005091:Exons / Q000235:genetics; D005334:Fever / Q000209:etiology; D005799:Genes, Dominant; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D008297:Male; D020125:Mutation, Missense; D010146:Pain / Q000209:etiology; D010507:Periodicity; D017354:Point Mutation; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D047888:Receptors, Tumor Necrosis Factor, Type I / Q000235:genetics*; D013577:Syndrome; D013602:T-Lymphocytes, Cytotoxic / Q000473:pathology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D047888:Receptors, Tumor Necrosis Factor, Type I; C506235:TNFRSF1A protein, human; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept